CIK 0002019410 · Non-accelerated filer<br>Emerging growth company
Caris Life Sciences, Inc.
Sign in to watch- Ticker
- CAI
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- TX
- Entity type
- operating
- EIN
- 852077369
- Phone
- (866) 771-8946
- Business address
- 750 W JOHN CARPENTER FREEWAY, SUITE 800, IRVING, TX, 75039
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Option exercise Director acquired 2,500 shares (option exercise)
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Planned sale See Remarks sold 62,250 shares at an average $26.58 ($1,654,461)
- 4 Gift See Remarks gave 1,300 shares (gift)
- 144 Insider Sale of Securities
- 4 Open-market buy See Remarks bought 4,184 shares at $24.09 ($100,793)
- 4 Open-market buy President bought 400 shares at $23.85 ($9,540)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change
- 4 Option exercise Director acquired 100,000 shares (option exercise)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Shares withheld for taxes Director gave up 139,517 shares (to pay taxes)
- 4 Shares withheld for taxes President gave up 63,509 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 141,956 shares (to pay taxes)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 4 of 7 · 134 filings